Revenue

3 Months Ended

Mar. 31, 2019

Revenue:

Revenue

NOTE 10. Revenue

The Company’s revenue consists of pharmaceuticals sales and patient care revenue.

	Three Months Ended March 31,
	2019		2018
	(Unaudited)		(Unaudited)
Pharmaceuticals:
Western pharmaceuticals	$	2,210,930	$	2,159,439
Chinese medicine		364,710		433,217
Herbal medicine		238,908		115,390
Total pharmaceuticals	$	2,814,548	$	2,708,046
Patient services:
Medical consulting	$	2,033,864	$	2,091,465
Medical treatment		2,582,429		1,981,455
Others		141,262		19,111
Total patient services	$	4,757,555	$	4,092,031
	$	7,572,103	$	6,800,077